Stephanie Kolmos
Payments from drug & device makers
Across 144 payments — averaging $20.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$631
- Scilex Pharmaceuticals Inc.$503
- Biogen$315
- Organon$279
- Novo Nordisk$235
- Neurocrine Biosciences, Inc.$175
- plus $820 from 19 others
What the payments were for
- Food & beverage$2,958100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 36 | $631 |
| Scilex Pharmaceuticals Inc. | 30 | $503 |
| Biogen | 15 | $315 |
| Organon | 4 | $279 |
| Novo Nordisk | 16 | $235 |
| Neurocrine Biosciences, Inc. | 5 | $175 |
| Pfizer | 6 | $130 |
| Lilly USA, LLC | 6 | $103 |
| GSK | 4 | $95 |
| Relievant Medsystems, Inc. | 1 | $89 |
| Sanofi-aventis U.S. LLC | 4 | $74 |
| Merck | 2 | $37 |
| Exact Sciences | 2 | $32 |
| Abbott | 1 | $31 |
| SK Life Science, Inc. | 2 | $27 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $24 |
| Novartis | 1 | $23 |
| Philips North America LLC | 1 | $23 |
| Lundbeck LLC | 1 | $23 |
| Si-bone, Inc. | 1 | $22 |
| Genentech USA, Inc. | 1 | $22 |
| Kowa Pharmaceuticals America, Inc. | 1 | $19 |
| Sunovion Pharmaceuticals Inc. | 1 | $17 |
| Dexcom, Inc. | 1 | $17 |
| AstraZeneca | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NEXPLANON$201
How this compares
$2,958 in reported general payments places this provider in the 90th percentile of 10,634 family providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levetiracetam | 40 | $1,267 |
| Donepezil Hcl | 27 | $389 |
| Gabapentin | 27 | $357 |
| Memantine Hcl | 11 | $334 |
| Mirtazapine | 11 | $165 |
| Topiramate | 13 | $164 |
| Cyclobenzaprine Hcl | 33 | $122 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 14 | $93 |
| Nortriptyline Hcl | 14 | $67 |
Paid to pharmacies, not to this prescriber.
Other family in Vista
- Lori RobertsonChino Hills$475K
- Annette ShonLos Angeles$406K
- Nancy GardettoSan Diego$394K
- Lisa HigginsHanford$311K
- Jennifer TougasBakersfield$302K
- Kim SchaferSacramento$288K
- Dawn MeyerSan Diego$270K
- Jennifer KangCerritos$255K
- Jenine StoneEscondido$231K
- Erin DwyerSan Diego$189K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.